PHIO PHARMACEUTICALS CORP. Operating Lease, Liability, Noncurrent
PHIO PHARMACEUTICALS CORP. (PHIO) had Operating Lease, Liability, Noncurrent of $0 as of 2024-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2025-03-31
- 2024-12-31: Operating Lease, Liability, Noncurrent $0.00.
- 2023-12-31: Operating Lease, Liability, Noncurrent $0.00.
- 2023-09-30: Operating Lease, Liability, Noncurrent $0.00.
- 2023-06-30: Operating Lease, Liability, Noncurrent $0.00.
| Period end | Operating Lease, Liability, Noncurrent |
|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-31 |
| 2023-12-31 | $0.00 10-K · filed 2025-03-31 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-09 |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-10 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-11 |
| 2022-12-31 | $35.00K 10-K · filed 2024-04-01 |
| 2022-09-30 | $70.00K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $104.00K 10-Q · filed 2022-08-11 |
| 2022-03-31 | $138.00K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $170.00K 10-K · filed 2023-03-22 |
| 2021-09-30 | $202.00K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $234.00K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $265.00K 10-Q · filed 2021-05-13 |
| 2020-12-31 | $295.00K 10-K · filed 2022-03-22 |
| 2020-09-30 | $325.00K 10-Q · filed 2020-11-10 |
| 2020-06-30 | $354.00K 10-Q · filed 2020-08-12 |
| 2020-03-31 | $383.00K 10-Q · filed 2020-05-12 |
| 2019-12-31 | $411.00K 10-K · filed 2021-03-25 |
| 2019-09-30 | $438.00K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $465.00K 10-Q · filed 2019-08-12 |
| 2019-03-31 | $500.00K 10-Q · filed 2019-05-14 |
| 2018-12-31 | $0.00 10-K · filed 2020-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |